Helio Risk’s Grace Topete was featured in a recent article on the struggle to find affordable insurance for psychedelic-assisted care. As Director of Business Operations and Senior Account Manager, Topete explains that because psychedelics remain federally classified as Schedule I substances, insurers routinely exclude coverage, but captive insurance can fill those gaps for facilitation centers, researchers, and advocacy groups. The piece also features Matt Grimes, a business attorney and chief insurance officer of the National Psychedelics Association, who is launching a Nevada-domiciled association captive for psilocybin-assisted care this summer. Together, their insights show how the industry is building coverage for an emerging field.
